| Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases T Jelinek, C Schulte, R Behrens, MP Grobusch, JP Coulaud, Z Bisoffi, ... Clinical Infectious Diseases 34 (5), 572-576, 2002 | 291 | 2002 |
| Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness AR Falsey, JE McElhaney, J Beran, GA Van Essen, X Duval, M Esen, ... The Journal of infectious diseases 209 (12), 1873-1881, 2014 | 254 | 2014 |
| Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients NKC Tong, J Beran, SA Kee, JL Miguel, C SanNchez, JM Bayas, A Vilella, ... Kidney international 68 (5), 2298-2303, 2005 | 245 | 2005 |
| Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo … H Montgomery, FDR Hobbs, F Padilla, D Arbetter, A Templeton, ... The Lancet Respiratory Medicine 10 (10), 985-996, 2022 | 206 | 2022 |
| AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial JE McElhaney, J Beran, JM Devaster, M Esen, O Launay, G Leroux-Roels, ... The Lancet infectious diseases 13 (6), 485-496, 2013 | 173 | 2013 |
| Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop N Mühlberger, T Jelinek, J Gascon, M Probst, T Zoller, M Schunk, J Beran, ... Malaria journal 3, 1-7, 2004 | 130 | 2004 |
| Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data N Mühlberger, T Jelinek, RH Behrens, I Gjørup, JP Coulaud, J Clerinx, ... Clinical infectious diseases 36 (8), 990-995, 2003 | 129 | 2003 |
| Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients J Beran Expert opinion on biological therapy 8 (2), 235-247, 2008 | 122 | 2008 |
| Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04 G Boland, J Beran, M Lievens, J Sasadeusz, P Dentico, H Nothdurft, ... Vaccine 23 (3), 316-320, 2004 | 122 | 2004 |
| Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial J Beran, A Ambrozaitis, A Laiskonis, N Mickuviene, P Bacart, Y Calozet, ... BMC medicine 7, 1-15, 2009 | 116 | 2009 |
| Imported schistosomiasis in Europe: sentinel surveillance data from TropNetEurop MP Grobusch, N Mühlberger, T Jelinek, Z Bisoffi, M Corachan, G Harms, ... Journal of travel medicine 10 (3), 164-169, 2003 | 113 | 2003 |
| A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients NCT Kong, J Beran, SA Kee, JL Miguel, C Sánchez, JM Bayas, A Vilella, ... Kidney international 73 (7), 856-862, 2008 | 93 | 2008 |
| Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example J Beran, V Wertzova, K Honegr, E Kaliskova, M Havlickova, J Havlik, ... BMC infectious diseases 9, 1-11, 2009 | 86 | 2009 |
| Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe O Wichmann, N Muehlberger, T Jelinek, M Alifrangis, GP Hoffmann, ... Journal of Infectious Diseases 190 (9), 1541-1546, 2004 | 85 | 2004 |
| Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule I Schöndorf, J Beran, D Cizkova, V Lesna, A Banzhoff, O Zent Vaccine 25 (8), 1470-1475, 2007 | 82 | 2007 |
| Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults J Beran, M Peeters, W Dewé, J Raupachová, L Hobzová, JM Devaster BMC infectious diseases 13, 1-10, 2013 | 78 | 2013 |
| Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults O Zent, J Beran, W Jilg, T Mach, A Banzhoff Vaccine 21 (7-8), 738-741, 2003 | 76 | 2003 |
| Očkování: minulost, přítomnost, budoucnost J Beran, J Havlík, V Vonka Galén, 2005 | 74 | 2005 |
| The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis? RH Behrens, B Carroll, J Beran, O Bouchaud, U Hellgren, C Hatz, ... Malaria Journal 6, 1-7, 2007 | 73 | 2007 |
| Lexikon očkování J Beran, J Havlík Maxdorf, 2008 | 71 | 2008 |
Martin Peter GrobuschProfessor of Tropical Medicine and Travel Medicine, Academic Medical Center, Universtiy of AmsterdamVerified email at amc.uva.nl
